ALSET GROUP
HOME
ABOUT
LEADERSHIP
DIVISIONS
INVESTORS
CONTACT
More
11 April 2018
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
10 April 2018
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)
12 March 2018
6 March 2018
Reconstitution of Nominating Committee
28 February 2018
27 February 2018
Singapore eDevelopment Limited (Stock Code 40V)’s biomedical subsidiary confirms the LB2 drug efficacy against Ebola
Financial Statements and Related Announcement::Full Yearly Results
31 January 2018
Financial Statements and Related Announcement::Profit Guidance
Sign up for our newsletter, so you can receive our latest press release, as well as general Alset International updates throughout the year.
Thanks for subscribing!
